The N-terminal region of centrosomal protein 290 (CEP290) restores vision in a zebrafish model of human blindness by Baye, Lisa M. et al.
The N-terminal region of centrosomal protein 290
(CEP290) restores vision in a zebraﬁsh model of
human blindness
Lisa M. Baye1, Xiaobai Patrinostro1, Svetha Swaminathan1, John S. Beck2,4, Yan Zhang2,4,
Edwin M. Stone3,4, Val C. Shefﬁeld2,4 and Diane C. Slusarski1,∗
1Department of Biology,
2Department of Pediatrics and
3Department of Ophthalmology and Visual Sciences,
University of Iowa, Iowa City, IA, USA and
4Howard Hughes Medical Institute, Chevy-Chase, MD, USA
Received December 14, 2010; Revised and Accepted January 18, 2011
The gene coding for centrosomal protein 290 (CEP290), a large multidomain protein, is the most frequently
mutated gene underlying the non-syndromic blinding disorder Leber’s congenital amaurosis (LCA).
CEP290 has also been implicated in several cilia-related syndromic disorders including Meckel–Gruber syn-
drome, Joubert syndrome, Senor–Loken syndrome and Bardet–Biedl syndrome (BBS). In this study, we
characterize the developmental and functional roles of cep290 in zebraﬁsh. An antisense oligonucleotide
[Morpholino (MO)], designed to generate an altered cep290 splice product that models the most common
LCA mutation, was used for gene knockdown. We show that cep290 MO-injected embryos have reduced
Kupffer’s vesicle size and delays in melanosome transport, two phenotypes that are observed upon knock-
down of bbs genes in zebraﬁsh. Consistent with a role in cilia function, the cep290 MO-injected embryos
exhibited a curved body axis. Patients with LCA caused by mutations in CEP290 have reduced visual percep-
tion, although they present with a fully laminated retina. Similarly, the histological examination of retinas
from cep290 MO-injected zebraﬁsh revealed no gross lamination defects, yet the embryos had a statistically
signiﬁcant reduction in visual function. Finally, we demonstrate that the vision impairment caused by the
disruption of cep290 can be rescued by expressing only the N-terminal region of the human CEP290 protein.
These data reveal that a speciﬁc region of the CEP290 protein is sufﬁcient to restore visual function and this
region may be a viable gene therapy target for LCA patients with mutations in CEP290.
INTRODUCTION
Mutations in centrosomal protein 290 (CEP290) cause the
non-syndromic blinding disorder Leber’s congenital amauro-
sis (LCA10, OMIM 611755) as well as several cilia-based
syndromic disorders including Meckel–Gruber syndrome
(MKS4, OMIM 611134), Joubert syndrome (JSTS5, OMIM
610188), Senor–Loken syndrome (SLSN6, OMIM 610189)
and Bardet–Biedl syndrome (BBS14, OMIM 209900). The
CEP290 protein is encoded by 54 exons, is 2479 amino
acids in length and has 25 predicted protein domains,
motifs and localization signals (1). Disease-causing
mutations including missense, nonsense, splicing and frame
shifting changes occur throughout the length of the protein
(2,3). To date, no clear correlations between phenotype and
the corresponding genotype have been identiﬁed between
CEP290 mutations and observed diseases (2); therefore, it
has been difﬁcult to understand the precise role and the func-
tional domains of this large protein. Moreover, although
these diseases have some overlapping phenotypes, there is
variability in the severity of disease states and organ involve-
ment, which is consistent with the idea that the protein has
tissue-speciﬁc roles that manifest differently based on the
genotype.
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microtubule-associated protein transport and localizes to cen-
trioles as well as to the connecting cilium of the photoreceptor
cell (1,4). The photoreceptor is a highly polarized, light-
sensing cell of the retina. The cell body, where protein
synthesis occurs, is found in the outer nuclear layer and is con-
nected to the outer segment, where phototransduction occurs,
via a modiﬁed cilium called the connecting cilium. The con-
necting cilium transports proteins critical for development,
maintenance and function of the photoreceptor from the cell
body to the outer segment through the process of intraﬂagellar
transport (5–10). Changes or disruptions in proper protein
trafﬁcking have been shown to result in photoreceptor
degeneration and ultimately blindness (9,11,12). LCA is an
early-onset blinding disorder in which most patients present
in infancy with a lack of visual response but relatively
normal retina (13–15). Mutations in CEP290 account for up
to 30% of all LCA cases, and the most common CEP290
mutation accounts for  43% of the disease-causing variations
in this gene (13,15,16). This common CEP290 allele is an
intronic mutation that disrupts normal splicing of the transcript
resulting in a premature stop codon; however, this particular
mutation is considered hypomorphic as some wild-type tran-
script is still present in the homozygous affected individuals
(17).
Two genetic animal models are currently being used to
study the role of CEP290 in vision, the rd16 mouse and the
rdAc cat. The rd16 mouse possesses an in-frame deletion of
amino acids 1599–1897 and presents with a severe,
early-onset retinal degeneration that exhibits decreased rod
and cone function by post-natal day 18 (4). The rdAc cat
harbors an intronic mutation that causes an aberrant splicing
of the transcript in intron 50 resulting in a truncated protein
that is missing the last 159 amino acids (18). rdAc cats
exhibit late-onset retinal degeneration (18). The variation in
the phenotypes observed between these animal models of
LCA with unique genotypes led us to examine the develop-
mental role of cep290 relative to vision in the zebraﬁsh
system by speciﬁcally targeting a region of the cep290 gene
that would model the most common human CEP290 mutation
causing LCA in patients, c.2991 + 1655A . G( 17). We then
performed structural/functional analysis of CEP290 by testing
the sufﬁciency of speciﬁc regions of the human CEP290
protein to suppress gene knockdown defects. Finally, we
tested the ability of these regions to bind nephronophthisis-2
(NPHP2), a known member of complexes in the retina pro-
posed to affect retinal degeneration (19).
cep290knockdowninzebraﬁshhasbeenpreviouslyshownto
result in several phenotypes including convergence extension
defects, hydrocephalus, small eyes, kidney cysts and body cur-
vature (1,20–22). In our targeted knockdown of cep290 in zeb-
raﬁsh,weobservedcurvatureofthebodyaxisindicativeofcilia
dysfunction. Mutation of CEP290 has been reported in a single
individualwithphenotypicfeaturesoverlapping BBS(resulting
in the alternative gene name BBS14). We evaluated our cep290
knockdown embryos and found that they exhibited two pheno-
types shared when all bbs genes are knocked down to date
(bbs1–13) in zebraﬁsh, reduced Kupffer’s vesicle (KV) size
and delayed retrograde melanosome transport (23–26)
(LisaM.BayeandJohnS.Beck,unpublisheddata).Histological
examination of the developing retina in cep290 knockdown
embryos revealed no gross lamination defects; however, func-
tionalanalysisof vision revealed areduction invisual behavior.
Importantly, we were able to restore visual responsiveness by
expressing only the N-terminal region of the human CEP290
protein in the knockdown embryos. This observation indicates
that the N-terminal region of the CEP290 gene is sufﬁcient to
suppress the visual impairment and may be a viable treatment
option for LCA patients.
RESULTS
cep290 is expressed throughout development in several
tissues including the KV and eye
To understand the functional role of cep290 in the zebraﬁsh,
we ﬁrst examined the spatial–temporal expression pattern of
the gene throughout development and in adult tissues.
Reverse transcriptase–polymerase chain reaction (RT–PCR)
analysis revealed that the cep290 transcript is inherited mater-
nally and is present throughout all stages of development
(Fig. 1A). cep290 is also expressed in the adult zebraﬁsh
eye and, speciﬁcally, in the retina (Fig. 1A) as well as in
all other tissues examined (data not shown). Whole-mount
in situ hybridization at the 8-somite stage shows that the
gene is ubiquitously expressed early in development
(Fig. 1B and C). Of note, cep290 is present around the KV
(Fig. 1D), which is a ciliated structure found transiently in
the posterior tailbud and contributes to left–right patterning
of the embryo (27). In 5-day post-fertilization (dpf)
embryos, cep290 is found in several tissues including the
brain, eye, ear, notochord and the gut region when compared
with the control embryo with no antisense probe added
(Fig. 1E and F). Sectioning of the 5 dpf retina revealed
cep290 expression in the ganglion cell layer (GCL), portions
of the inner nuclear layer (INL) as well as the photoreceptor
cell layer (PR) (Fig. 1G and H).
cep290 gene targeting and gross morphology of knockdown
embryos
The most common human CEP290 mutation underlying LCA
is an intronic mutation, c.2991 + 1655A . G, which alters
gene splicing and results in a stop at amino acid C998X
(Fig. 2A) (17). We mimicked this LCA mutation in zebraﬁsh
by using an antisense Morpholino (MO) that disrupts the spli-
cing of the zebraﬁsh cep290 transcript at the corresponding
exon 25 leading to intron inclusion (Fig. 2A, hashed bar).
cep290 MO-injected embryos (morphants) exhibit body cur-
vature defects in a MO dose-dependent manner ranging from
straight to a severe C-shaped (curly) axis at 5 dpf (Fig. 2B).
The curly body shape is similar to that observed in the cilia
mutant seahorse, as well as in previously published cep290
exon 42-targeted knockdown zebraﬁsh embryos (21,28).
This body morphology defect is consistent with our obser-
vation that the cep290 transcript is expressed in the developing
notochord (Fig. 1F). Embryos injected with the highest dose of
MO (10 ng) had the greatest percentage of curly embryos
(80%), whereas only 34% of embryos injected with
1468 Human Molecular Genetics, 2011, Vol. 20, No. 8low-dose (5 ng) MO presented with the curly body axis
(Table 1).
To verify disrupted splicing in the straight body morphant
embryos, primers were designed to ﬂank intron 25 (Fig. 2A).
MO-injected embryos (8 ng dose) with a straight body axis
were pooled for RNA isolation and RT–PCR was performed.
Uninjected embryo cDNA ampliﬁed the expected wild-type
transcript (Fig. 2C). cep290 MO-injected embryos presented
a larger transcript consistent with intron inclusion (Fig. 2C).
Indeed, sequence analysis of the product revealed inclusion
of intron 25 which generates a frame shift that introduces a
stop six amino acids past the coding amino acid 1018 in the
zebraﬁsh transcript (Fig. 2A). This aberrant transcript is
present from the 8–10-somite stage through 5 dpf (Fig. 2C).
Additionally, some wild-type transcript is present in the mor-
phant embryos, and we posit that having some wild-type tran-
script indeed makes this model more similar to LCA patients
with the hypomorphic c.2991 + 1655A . G mutation.
cep290 morphants have the cardinal zebraﬁsh BBS
phenotypes
We have previously described cilia- and transport-related
defects observed with the knockdown of bbs genes in zebraﬁsh
(23–26). All bbs genes tested resulted in abnormal KV size
and delayed retrograde melanosome transport in the skin
pigment; therefore, we examined these cardinal features in
cep290 morphant embryos (23–26).
The KV is a ciliated organ found transiently in the posterior
tailbud of developing embryos from 6–15 somites (Fig. 3A).
The size of the KV is assessed at the 8–12-somite stage by
comparing the vesicle width to the width of the developing
notochord. Embryos with a KV larger than the width of the
notochord are considered normal (Fig. 3B), whereas a KV
that is the same size or smaller than the width of the notochord
is considered abnormal (Fig. 3C). We determined that the
knockdown of cep290 results in a statistically signiﬁcant per-
centage of embryos with abnormally sized KVs, 20.8% at the
10 ng dose, compared with 5.6% of wild-type (Fisher’s exact
test, ∗∗P , 0.01; Fig. 3D). The percentage of embryos with
abnormal KVs increased in a MO dose-dependent manner.
The second cardinal feature of BBS assessed in zebraﬁsh
was the rate of melanosome movement, which is a method
to examine intracellular transport. Under standard conditions,
zebraﬁsh embryos adapt to their environment by trafﬁcking
their melanosomes (pigment) within the melanophores in
response to light and/or hormonal stimuli (29–31). The
average time of melanosome transport is assessed by treating
5 dpf dark-adapted embryos with epinephrine to chemically
stimulate movement. Dark adaptation maximally disperses
the melanosomes throughout the melanophore (Fig. 3E and
F), whereas epinephrine treatment results in rapid retrograde
movement of melanosomes to the perinuclear region
(Fig. 3G) (23–26,32). Completion of melanosome transport
in wild-type embryos averages 1.58 min, whereas cep290 mor-
phant embryos at all doses showed a statistically signiﬁcant
delay with the 10 ng dose averaging 2.50 min (Fig. 3H,
ANOVA with Tukey, ∗P , 0.05, ∗∗P , 0.01). Together,
these data indicate that the knockdown of the cep290 tran-
script results in the cardinal BBS phenotypes in the zebraﬁsh
supporting a role for CEP290 in some patients with BBS.
cep290 morphants exhibit a vision defect with normal
retinal lamination
To assess the role of cep290 in the developing retina, we per-
formed histological analysis by hematoxylin and eosin (H&E)
staining of morphant embryos at 3 and 5 dpf. For these ana-
lyses, we selected the moderate MO dose (8 ng) because it
led to intron inclusion through 5 dpf (Fig. 2C) and displayed
both the straight and the curved body axis phenotypes
(Fig. 2B). We determined that regardless of body curvature,
morphant embryos had a fully laminated retina at 3 dpf
(Fig. 4C and D). Additionally, the photoreceptor outer
Figure 1. cep290 transcript expression throughout development and in adult
tissues. (A) RT–PCR of the cep290 transcript in wild-type embryos
showing expression at all the stages and tissues examined: maternal, 8–10
somites, 48 hpf, 5 dpf, adult retina and adult whole eye. b-actin expression
served as a loading control. (B–H) Whole-mount in situ hybridization using
an antisense probe corresponding to a portion of the cep290 gene (see
Materials and methods). Control embryos had no cep290 antisense probe
added to the reaction. (B and C) Side view of a control and cep290 hybridized
embryos at 8-somites. The cep290 transcript is present ubiquitously.
(D) Dorsal view of the 8-somite embryo revealing that cep290 is expressed
around the KV (circle). (E and F) Side view of a control and cep290 hybri-
dized embryos at 5 dpf. The cep290 transcript is present in several tissues
including the brain (arrow) and notochord (arrowhead). (G and H) Transverse
sections of the eye at 5 dpf. The cep290 transcript is present in the GCL, por-
tions of the INL and the PR cells. GCL, ganglion cell layer; IPL, inner plexi-
form layer; INL, inner nuclear layer; PR, photoreceptors.
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compared with wild-type and control-injected embryos
(Fig. 4G and H). In contrast to the parallel organization of
the extending outer segments in wild-type and control-injected
embryos, the extending outer segments of cep290 morphants
appeared more wavy, suggesting modest disorganization at
5 dpf (Fig. 4K and L).
Since patients with LCA caused by mutations in CEP290
have been shown to present with and maintain a fully lami-
nated retina and sparing of some photoreceptor cells yet has
reduced visual perception, we sought to functionally assess
vision in the cep290 morphants (14,33). To evaluate visual
function in zebraﬁsh, we utilized a natural escape response
that is elicited when embryos are exposed to rapid changes
in light intensity (26,34,35). In the vision assay, visually
responsive 5 dpf embryos change their swimming behavior
when there is a short block in a bright light source
(Fig. 4M–O, Supplementary Material, Movies S1 and S2).
The assay is repeated ﬁve times spaced 30 s apart, and the
average number of responses is reported. Wild-type embryos
respond an average of 3.53 times (Fig. 6). As a control for
the assay, the visually impaired cone-rod homeobox (crx) mor-
phant embryos were utilized and responded only 2.00 times
(Fig. 6)( 26,35). Only cep290 morphant embryos that pos-
sessed a straight body axis were used for this behavioral
assay to ensure uncompromised locomotor activity (Sup-
plementary Material, Fig. S1). In contrast to wild-type and
control MO-injected embryos, cep290 morphants responded
only 2.46 times during the ﬁve trials (ANOVA with Tukey,
P , 0.01). The range of responses for each experimental set
of embryos is depicted in Supplementary Material, Figure
S2. The majority of wild-type and control MO-injected
embryos, 67 and 54%, respectively, responded 4–5 times in
the assay of ﬁve trials, whereas only 19% of the cep290 mor-
phants and 16% of the crx morphants responded as many
times. These observations indicate that the cep290 morphant
embryos have reduced visual activity.
N- and C-terminal truncation constructs of CEP290
localize to centrioles
Having shown that cep290 morphant embryos have overall
normal retina histology but still present with a vision defect,
Table 1. Percentages of embryos with body curvature defects based on MO
dose
Experimental group Phenotype (percentage) n
Straight Bent Curly
Wild-type 100 0 0 129
cep290 MO (5 ng) 60 6 34 205
cep290 MO (8 ng) 40 5 55 282
cep290 MO (10 ng) 13 7 80 208
Figure 2. cep290 gene targeting and gross morphant phenotypes. (A) Sche-
matic of full-length human (white) and zebraﬁsh (gray) CEP290 proteins.
The most common CEP290 mutation in LCA patients (C998X) is noted.
The location of the splice-blocking MO is depicted by the hashed bar and
the ﬂanking primers used for RT–PCR are shown with black arrows. The
open reading frame for the region of interest is depicted with amino acids
highlighted in gray representing the sequence from exons 25 and 26 ﬂanking
the included intron sequence that begins at amino acid 1018. Asterisks rep-
resent the stop codons. (B) Live images of 5 dpf wild-type, control-injected
and cep290 morphant embryos representing the range of gross morphology
observed. MO-injected embryos presented with body plans that were straight,
bent or curly in a MO dose-dependent manner (Table 1). (C) RT–PCR from
wild-type and cep290 morphant embryos injected with 8 ng of MO at the fol-
lowing stages: 8–10 somites, 72 hpf and 5 dpf. Only morphants with a straight
body axis at 72 hpf and 5 dpf were used to assess the gene knockdown. The
aberrantly spliced cep290 transcript in morphant embryos (intron inclusion)
is present through 5 dpf. b-actin expression served as a loading control.
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of the CEP290 protein that are sufﬁcient to suppress the vision
defect. Indeed, if a smaller portion of this protein is sufﬁcient
to restore vision, then it alone could be used for gene therapy
in patients using the standard retroviral techniques that are
currently available. We, therefore, divided the human
CEP290 gene into an N-terminal fragment that represents
the ﬁrst 1059 amino acids of the protein (Fig. 5A, blue) and
a C-terminal fragment, amino acids 1765–2479 (Fig. 5A,
green). Both of these constructs contain regions that have pre-
viously been shown to form multimers by homodimerization
(21). The N-terminal construct extends over the region
where the most common LCA mutation is found (noted in
Fig. 5A). The C-terminal construct contains a large portion
of the predicted myosin-tail domain of CEP290 that has
been hypothesized to play a vision-speciﬁc role as this
region is partially deleted in the rd16 mouse model of
retinal degeneration (deletion of amino acids 1599–1897)
(4). Additionally, this construct covers the entire region that
is truncated in the rdAc cat model of late-onset retinal
degeneration (18).
We ﬁrst evaluated expression and localization of the human
CEP290 N- and C-terminal constructs in zebraﬁsh. mRNA
encoding myc-tagged fusion constructs were injected into zeb-
raﬁsh embryos and immunohistochemistry was performed.
Immunostaining using anti-myc antibody revealed the
expression of the constructs at 50% epiboly [ 6 hpf (hours
post-fertilization); Fig. 5B and E]. Since full-length CEP290
localizes closely with the centrioles in tissues and cell lines
(1,4), zebraﬁsh centrin fused to green fluorescent protein
(eGFP) was co-injected as a marker for the centriole
(Fig. 5C, F and I). With both the N-terminal and the C-
terminal constructs, we observed some paracentriolar as well
as cytoplasmic localization (Fig. 5D and G). To verify the
localization of the proteins in ciliated cells, we expressed the
N-terminal and the C-terminal constructs in undifferentiated
and ciliated ARPE-19 cells and found both constructs to be
paracentriolar (Supplementary Material, Figs S3 and S4).
N-terminal region sufﬁcient to rescue the vision defect
We next assessed if the human constructs can function in zeb-
raﬁsh to rescue the MO-induced vision defect. Embryos
co-injected with cep290 MO and the mRNA encoding myc-
tagged N- and C-terminal constructs were grown to 5 dpf.
Again, only morphant embryos with a straight body axis
were used in the vision assay to ensure proper embryo motility
(Supplementary Material, Fig. S1). In the vision assay, cep290
morphant embryos responded on average 2.46 times, whereas
morphant embryos injected with the N-terminal CEP290 con-
struct responded 3.48 times (Fig. 6). This response was statisti-
cally the same as the wild-type response of 3.53, indicating the
rescue of the MO-induced vision defect. The number of
cep290 morphant embryos injected with the N-terminal con-
struct that now responded 4–5 times in the assay rose to
53% from 19% in the MO alone (Supplementary Material,
Fig. S2). Conversely, injection of the C-terminal construct
was unable to rescue the vision defect (Fig. 6; ANOVA with
Tukey, ∗∗P , 0.01). Neither the N-terminal nor the C-terminal
construct was sufﬁcient to rescue the KV size defect and only
Figure 3. cep290 gene knockdown results in zebraﬁsh BBS cardinal features.
(A) Side view of a 10-somite embryo highlighting the location of the ciliated
KV (circle) in the tailbud. (B and C) Dorsal views of an average-sized KV
and an abnormally reduced in KV size, respectively, (arrow heads) at the
10-somite stage. The notochord is marked with an ‘N’. Embryos were scored
has having an abnormal KV if the vesicle was less than the width of the noto-
chord. (D) The percentage of wild-type, control-injected and cep290 morphant
embryos with abnormal KVs.MOconcentration and thenumberof embryos (n)
are noted on the x-axis. ∗∗P , 0.01, Fisher’s exact test when compared with
wild-type. (E) Dorsal view of the head melanocytes of a 5 dpf dark-adapted
wild-type embryo. The boxed region represents the zoomed region for F and
G. (F) Dark-adapted melanocytes prior to epinephrine treatment note the dis-
persed melanosomes. (G) The end point, perinuclear localization of melano-
somes, after epinephrine treatment. (H) Epinephrine-induced retrograde
transport times for wild-type, control-injected and cep290 morphants. MO con-
centration and the number of embryos (n) are noted on the x-axis. ∗P , 0.05,
∗∗P , 0.01, ANOVA with Tukey when compared with wild-type.
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some transport delay (Table 2). Taken together, these data
indicate that the N-terminal region of the human CEP290
gene is sufﬁcient to rescue the cep290 MO-induced vision
defect. Additionally, because the N-terminal region cannot
rescue KV and melanosome transport defects, this indicates
that other regions of the protein are needed for these cellular
functions.
The N-terminal region of CEP290 binds NPHP2
It has been shown in the retina that several NPHP proteins,
including CEP290 (also known as NPHP6), form protein com-
plexes that interact with retinitis pigmentosa GTPase regulator
(RPGR), a protein known to affect retinal function (19).
Additionally, NPHP5 has been shown to directly bind a
region found within our N-terminal fragment of CEP290,
and mutations in NPHP5 cause some cases of the syndromic
blinding disorder renal–retinal SLSN (21,36). To explore a
mechanism by which the N-terminal region of CEP290 may
function in vision, we examined whether another NPHP
complex component in the retina, NPHP2, binds to either
the N-terminal or the C-terminal regions of CEP290 (19).
Like NPHP5, a mutation in NPHP2 has also been associated
with vision impairment (37). By transient transfection and
co-immunoprecipitation (IP) assays, we ﬁnd that the N-
terminal, but not the C-terminal, region of CEP290 physically
interacts with NPHP2 (Fig. 7). These results provide further
evidence that the N terminus of CEP290 interacts with a
known protein complex necessary for vision.
DISCUSSION
CEP290 has been associated with several cilia-related dis-
eases, but the precise functional domains of the protein and
their role in normal development need to be determined. We
observed that the cep290 transcript is present throughout all
stages of zebraﬁsh embryo development and is enriched in
the KV region as well as in ganglion cells, the INL and photo-
receptor cells of the retina. Using a targeted knockdown strat-
egy to model the most common CEP290 mutation in LCA
patients, we found body curvature defects, KV size reduction,
delayed retrograde melanosome transport and vision impair-
ment. We determined by using truncated CEP290 constructs
that the N-terminal region of the CEP290 protein is sufﬁcient
to rescue the vision defect observed in cep290 knockdown
embryos. Finally, we determined that this N-terminal region
of the protein, but not the C-terminal region, can bind NPHP2.
LCA patients with the c.2991 + 1655A . G mutation are
hypomorphic in that some wild-type transcript is present in
Figure 4. Retinal histology and functional analysis of vision in cep290 morphants. (A–L) H&E staining of transverse retinal cryosections of wild-type,
control-injected and cep290 morphants with a straight or curly body axis. Scale bars ¼ 10 mm. (A–D) Whole eye images of 3 dpf wild-type, control-injected
and cep290 MO-injected embryos. The lens, GCL, INL and PR are labeled in (A). The white box represents the central region of the retina that was examined at
higher magniﬁcation in (E)–(L). (E–H) Zoom of PR cell layer in the central retina at 3 dpf. (I–L) Zoom of PR cell layer in the central retina at 5 dpf. ONL, outer
nuclear layer; IPL, inner plexiform layer; OS, outer segments of the photoreceptor cells. (M–O) Selected image from a time-lapse movie generated while per-
forming the vision startle response assay to test the visual function of 5 dpf embryos. (M) Embryo in bright light illumination. (N) A 1 s block in light. Image has
been contrast manipulated in Adobe Photoshop to visualize embryo. (O) Characteristic C-bend swimming behavioral response observed when the bright light
illumination is turned back on.
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present with non-syndromic LCA because there is enough
wild-type transcript present that other organ systems are unaf-
fected (17). Consistent with this hypothesis, we observe that
the penetrance of the curly body axis, as well as the severity
of the KV defect and melanosome transport delay, is MO
dose-dependent. We also show that although the splice-block
MO does induce an intron inclusion, there is still some wild-
type transcript present (Fig. 2C). Due to the lack of a
CEP290 antibody that speciﬁcally recognizes the endogenous
full-length or the N terminus of the protein in zebraﬁsh, we
cannot determine if the truncated protein is expressed from
this aberrantly spliced transcript. However, since MO-injected
embryos that do not show the curly body axis still have visual
impairment, it is likely that levels of cep290 are sufﬁcient for
normal axis development but are not sufﬁcient for normal
visual function.
Our ﬁnding that the expression of only the N-terminal region
of the CEP290 protein is sufﬁcient to rescue the vision defect
suggests that domains within this region are able to interact
with their retina-speciﬁc binding partners to allow visual func-
tion. The ability of the N-terminal region of the human CEP290
to rescue the vision defect observed in cep290 knockdown zeb-
raﬁsh embryos appears to be inconsistent with two existing
animal models, the rd16 mouse and the rdAc cat. Mutations in
these model systems are found in the C-terminal region,
suggesting that it is this region of the protein that is required
for vision. Possible explanations for this inconsistency include
that the mutant Cep290 protein in the mouse and cat models is
unstable and degraded, folds in such a manner as to affect the
structure of the N-terminal region resulting in alteration of
binding properties or results in changes in protein localization.
Ithasbeenshowninrd16micethatthereisareducedamountof
the mutant Cep290 protein; moreover, the mutant Cep290
protein has a higher than normal afﬁnity for RPGR, and the
RPGR protein aberrantly localizes to the photoreceptor inner
segment (4).
In human patients, there are several mutations found within
the N-terminal region of CEP290 that result in LCA, including
the mutation modeled in our study (2,3,16,17). This human
mutation analysis suggests that regions outside that of the C
terminus have a role in regulating binding to interacting pro-
teins required for proper vision. The identiﬁcation of NPHP
protein complexes that interact with proteins known to affect
vision has highlighted a molecular pathway to be further
investigated for its role in the retina (19). Here, we have
found that NPHP2 binds to only the N-terminal fragment
of CEP290, which rescues the vision defect, but not the C-
terminal construct, which suppresses the melanosome
transport delay. This differential binding to restore individual
phenotypes is an example of tissue speciﬁcity of protein func-
tion and highlights the importance of examining molecular
pathways in a tissue-speciﬁc manner. Together, these ideas
corroborate a hypothesis by Murga-Zamalloa et al.( 19), in
which the authors pose that the severity of a disease phenotype
is the result of the degree to which individual complexes are
disrupted.
Figure 6. Rescue of the cep290 morphant vision defect. Vision startle
response assay for wild-type, control-injected, cep290 morphants and rescue
experiments. Experimental group and the number of embryos (n) are noted
on the x-axis. The N-terminal RNA is sufﬁcient to rescue the cep290 morphant
vision defect. ∗∗P , 0.01, ANOVA with Tukey when compared with wild-
type.
Figure 5. Cellular localization of the N-terminal and the C-terminal trunca-
tions of the human CEP290 protein. (A) Schematic of wild-type full-length
human CEP290 protein with the N-terminal construct highlighted in blue
(amino acids 1–1059) and the C-terminal construct highlighted in green
(amino acids 1765–2479). The location of the common LCA human mutation,
C998X, is noted. (B–J) Immunohistochemistry at 50% epiboly of N-terminal
and C-terminal human myc-tagged CEP290 constructs and control
centrin-eGFP only injected embryo. Scale bars ¼ 10 mm. (B, E and H)
Anti-myc immunoactivity (red). (C, F and I) Centrin-eGFP (green) labeling
the centrioles. (D and G) Co-localization of centrin-eGFP and anti-myc strain-
ing revealing localization of both the N-terminal and the C-terminal regions of
the CEP290 protein in the cytoplasm and paracentriolar. Asterisks mark
co-localization of myc-CEP290 and centrin-eGFP. (J) Serves as a background
control for anti-myc and ﬂorescent secondary immunoreactivity. Nuclei are
labeled with ToPro3 (blue).
Human Molecular Genetics, 2011, Vol. 20, No. 8 1473In summary, we have identiﬁed a region of the CEP290
protein that is sufﬁcient to restore visual function in cep290
knockdown zebraﬁsh embryos. This construct rescues the
vision defect, suggesting domain and tissue-type speciﬁcity
for this region of the protein. Although gene therapy vectors
are being generated that are able to package large genes
such as the entire CEP290 coding region (38), the functional
characterization of a smaller portion of this protein sufﬁcient
to restore vision provides valuable information that can be
used for potential treatments of LCA patients. Finally, we
have begun to examine interacting partners with CEP290 to
determine how this shortened construct is able to functionally
rescue vision. We have shown that NPHP2, a known
component of an identiﬁed protein complex in the retina,
can bind the N-terminal construct that rescues the vision
defect but not the C-terminal piece. Future work will be
focused on elucidating the mechanism by which the N-
terminal region of CEP290 functions within the retina.
MATERIALS AND METHODS
Animal care
Zebraﬁsh embryos were collected from natural spawning and
maintained under standard conditions (39). Embryos were
developmentally staged as described previously (40).
Reverse transcriptase–polymerase chain reaction
RNA was extracted from pools of wild-type embryos at the
following stages: 1–128 cells (maternal stage), 8–10
somites, 48 hpf and 5 dpf, as well as the adult retina and
whole eye. cDNA was synthesized using oligo-dT primers.
Gene expression was evaluated using the following primers
whose location in the cep290 gene is depicted in Figure 2A.
b-actin expression served as a control.
cep290—primer F1: 5′-GGAACAGGCCTTTGAAAACA-3′
cep290—primer R1: 5′-GCAAACTTGGTCTCCAGCTC-3′
b-actin—primer F: 5′-TCAGCCATGGATGATGAAAT-3′
b-actin —primer R: 5′-GGTCAGGATCTTCATGAGGT-3′
Whole-mount in situ hybridization
A large 5′ segment of the zebraﬁsh cep290 open reading frame
(Ensemble v8: ENSDART00000090921) was TA cloned into
PCRII vector (Invitrogen) from a multistage pool of embryo-
nic cDNA. After digesting the vector with DraI, a
digoxigenin-UTP-labeled RNA probe was synthesized using
SP6 polymerase (Roche). The resulting  1.9 kb antisense
probe corresponds to 2784–4656 bp of the zebraﬁsh cep290
gene. Whole-mount in situ hybridization was performed as
described previously (41). Control embryos had no antisense
probe added in the reaction. For section analysis of the
retina, embryos were embedded in optimal cutting temperature
compound and 15 mm cryosections were collected.
cep290—primer F2: 5′GACTGGCAATCTCAGCATCAGT-3′
cep290—primer R2: 5′-GCGAGCCTTTCCTAGAAGGT-3′
MO knockdown
The antisense splice site MO was designed and purchased
from Gene Tools. The MO was air pressure injected into 1–
4-cell embryos at concentrations ranging from 5 to 10 ng.
The efﬁciency of transcript knockdown was assessed by
RT–PCR (described above) using cDNA generated from
pools of cep290 morphants with only the straight body axis
phenotype at the following stages: 8–10 somites, 72 hpf and
5 dpf.
Standard control MO: 5′-CCTCTTACCTCAGTTACAATT
TATA-3′
cep290 MO: 5′-TTGATGTGTACCAGTTGTGCTGATG-3′
Table 2. Compiled data set of KV, melanosome transport and vision startle
response assay results for rescue experiments
Experimental group KV
(%)
MT
(min)+SE
Vision
(responses)+SE
Wild-type 5.2 1.51+0.07 3.53+0.17
control MO (10 ng) 8.3 1.52+0.06 3.48+0.18
cep290 MO (8 ng) 18.2
++ 2.10+0.10∗∗ 2.46+0.12∗∗
cep290 MO (8 ng)
+ N terminus (1.8 ng)
22.6
++ 2.05+0.10∗∗ 3.48+0.13
cep290 MO (8 ng)
+ C terminus (0.6 ng)
15.4
++ 1.82+0.07 2.44+0.22∗∗
++Fisher’s Exact test P , 0.01.
∗∗
ANOVA with Tukey P , 0.01.
Figure 7. The N-terminal region of CEP290 interacts with NPHP2. FLAG or
GFP-tagged CEP290 expression constructs and Myc-tagged NPHP2 were
transfected into HEK293T cells, and lysates were subjected to co-IP and
immunoblotting (IB). Expression of each component in the lysate is found
in the bottom two panels. IPs were analyzed by SDS–PAGE and immunoblot-
ting using the Myc antibody and either the FLAG or the GFP antibodies shown
in the upper two panels. Myc-NPHP2 was only co-immunoprecipitated from
cells expressing N-terminal CEP290 fragment (top panel). FLAG-tagged
BBS3 served as a negative control.
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The KV size was assessed on live embryos between the 6–
12-somite stages of development as described previously
(23). Embryos with a KV smaller than the width of the noto-
chord were recorded as abnormal. The melanosome transport
assay was performed as described previously (23). Brieﬂy,
5 dpf dark-adapted embryos were treated with epinephrine
(500 mg/ml, Sigma E4375), and the quantity of time that it
took the melanosomes to trafﬁc from the periphery of the cell
to their perinuclear location was recorded. Embryos were
imaged live using a stereoscope with a Zeiss Axiocam camera.
Histological analysis
To minimize the pigmentation of the retinal pigmented epi-
thelium in order to view the outer segments of the photo-
receptor cells, embryos were maintained in 0.003%
phenylthiourea beginning at 80% epiboly and then ﬁxed in
4% paraformaldehyde in phosphate-buffered saline (PBS).
Gross morphology of the retinas was evaluated with standard
H&E staining.
Vision startle response assay
The vision-evoked startle-response behavioral assay was per-
formed as described previously (26,34,35). In brief, 5 dpf zeb-
raﬁsh embryos were light adapted, and the visual stimulus of a
1 s block in bright light intensity was performed under a dis-
secting microscope. A positive visual response was recorded
if the embryo made an abrupt change in swimming behavior
within 1 s of the light intensity change. Five trials were per-
formed spaced 30 s apart followed by the mechanical stimulus
of probing embryos with the tip of a blunt needle. Embryos
that did not respond to the mechanical stimulus were not
included in the analysis.
DNA constructs
The fragments encoding the N-terminal (1–1059 amino acids)
and the C-terminal regions (1765–2479 amino acids) of
human wild-type CEP290 (NCBI Reference Sequence:
NG_008417.1) were ampliﬁed from human retina cDNA (Clo-
netech), TA cloned into the Gateway vector system (Invitro-
gen) and sequence conﬁrmed. Subsequently, the genes were
recombined into gateway expression vectors with an N-
terminal 6× myc tag.
CEP290—primer N-terminal F: 5′-ATGCCACCTAATA
TAAACTGG-3′
CEP290—primer N-terminal R: 5′-TCATATTTTTTTT
GAAATGGAAACAATGTC-3′
CEP290—primer C-terminal F: 5′-ATGTCTGCAACTTCT
CAAAAAGAG-3′
CEP290—primer C-terminal R: 5′-TTAGTAAATGGG
GAAATTAACAGG-3′
Protein localization and rescue experiments
N-terminally tagged human myc-CEP290 RNA was syn-
thesized using the mMessage mMachine transcription kit
(Ambion) and injected into 1–2-cell embryos. Whole-mount
immunohistochemistry was performed on 50% epiboly stage
embryos as described (42) using an anti-myc antibody
(9E10, Santa Cruz) and ﬂuorescent secondaries (Alexa Fluor
568, Molecular Probes). The centrin-eGFP was detected by
direct GFP ﬂuorescence. For rescue experiments, the synthetic
RNA was co-injected with the cep290 MO.
Cell culture and immunoﬂuorescence microscopy
ARPE-19 cells were maintained in DMEM/F12 media (Invi-
trogen) supplemented with 10% fetal bovine serum (FBS)
and seeded on glass coverslips in 24-well plates. To induce
ciliogenesis, cells were shifted to serum-free medium 24 h
after seeding and further incubated for 48 h. Cells were ﬁxed
with methanol for 10 min at 48C, blocked with 5% bovine
serum albumin and 3% normal goat serum and stained with
indicated primary antibodies. Alexa Fluor 488 goat anti-rabbit
immunoglobulin (Ig) G (Invitrogen) and 568 goat anti-mouse
IgG (Invitrogen) were used to detect the primary antibodies.
Coverslips were mounted on Vecta-Shield mounting with
DAPI (Vector Lab), and images were taken with an
Olympus 1X71 inverted microscope. Antibodies were pur-
chased from the following sources: mouse monoclonal anti-
bodies against g-tubulin (GTU-88, Sigma) and
acetylated-tubulin (T7451, Sigma); rabbit polyclonal antibody
against Myc (ab9106, Abcam).
Cell culture and IP
HEK293T cells were grown in Dulbecco’s modiﬁcation of
Eagle’s medium (DMEM) (Invitrogen) supplemented with
10% FBS (Invitrogen). For individual protein–protein inter-
action studies, cells were transfected in 6-well plates with
total 1.5 mg indicated plasmids using Lipofectamine Reagent
(Invitrogen). After 30 h of incubation, cells were lysed in
the lysis buffer (PBS, 0.5% Triton X-100) supplemented
with Complete Protease Inhibitor Mixture (Roche Applied
Science). Lysates were immunoprecipitated with anti-Flag
and anti-GFP antibodies conjugated to agarose beads for 4 h
at 48C. Beads were washed in the lysis buffer four times,
and precipitated proteins were analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) and
western blotting following a standard protocol. Experiments
were repeated 2–3 times, with similar results. Antibodies
were purchased from the following sources: mouse mono-
clonal antibodies against Myc (9E10; Santa Cruz), FLAG
(M2; Sigma) and GFP (18A11, Santa Cruz).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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